Midjourney, the AI image-generation startup known for creating digital art, is making an unexpected move into healthcare.
Lupin enters hypertension drug market as it announced the commercial launch of Azilsartan Medoxomil tablets in the United States.
Specialty drugs are becoming the next big growth driver for Indian pharmaceutical companies as the industry looks beyond traditional generic medicines.
Glenmark's drug launch could be a game changer as it expands its presence in the high-value rare disease segment.
.jpeg "India Pharma Growth Broadens as Volumes Gain Momentum")
India’s pharma market shows balanced growth as rising volumes, steady pricing, and new launches drive sustained expansion across therapies and regions.
.jpeg "Hyderabad Emerges as Pharma R&D Hub with Neuland's $20M Bet")
Neuland’s $20M facility in Hyderabad strengthens Genome Valley’s position as a leading pharma innovation hub focused on advanced drug development.
Zydus Lifesciences has finalized its acquisition of Assertio Holdings, strengthening its position in the US specialty pharmaceutical market and expanding its presence across several high-value therapeutic segments.
The World Health Organization (WHO) has taken a major step toward improving child-focused dengue treatment with the publication of its first-ever Paediatric Drug Optimization Process (PADO) for dengue.
API prices are emerging as a key factor for India's pharmaceutical industry after a recent decline in the cost of active pharmaceutical ingredients (APIs).
Kiran Mazumdar-Shaw is placing one of Biocon's biggest bets on a market many pharmaceutical companies are no longer prioritizing. As global drugmakers rush to capitalize on the booming demand for GLP-1 and obesity drugs, the Biocon...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")